The therapeutic effect of adipose-derived MSCs on obesity-related complications (e.g., NAFLD, CVD, and renal diseases) in animal models of diet-induced obesity derives from the attenuation of inflammatory cytokines such as TNF-α and IL-6 [493]. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.